Evidence map›Paper›PMID 40033850›Full record

ArticleThe FEBS journal2025

Membrane selectivity and pore formation of SprA1 and SprA2 hemolytic peptides from Staphylococcus aureus type I toxin-antitoxin systems.

Laurence Fermon, Noëlla Germain-Amiot, Charlotte Oriol, Astrid Rouillon, Yoann Augagneur, Stéphane Dréano, Irène Nicolas, Alexandre Chenal, Arnaud Bondon, Soizic Chevance and 1 more

Abstract read
In one paragraph

Article in The FEBS journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Laurence FermonINSERM, BRM - UMR_S 1230, Univ Rennes, F-35000, Rennes, France.
Noëlla Germain-AmiotINSERM, BRM - UMR_S 1230, Univ Rennes, F-35000, Rennes, France.
Charlotte OriolINSERM, BRM - UMR_S 1230, Univ Rennes, F-35000, Rennes, France.
Astrid RouillonINSERM, BRM - UMR_S 1230, Univ Rennes, F-35000, Rennes, France.
Yoann AugagneurINSERM, BRM - UMR_S 1230, Univ Rennes, F-35000, Rennes, France.
Stéphane DréanoCNRS, IGDR - UMR 6290, BIOSIT, Univ Rennes, F-35000, Rennes, France.
Irène NicolasCNRS, ISCR - UMR 6226, Univ Rennes, F-35000, Rennes, France.
Alexandre ChenalBiochemistry of Macromolecular Interactions Unit, CNRS UMR3528, Institut Pasteur, Université de Paris Cité, F-75015, Paris, France.
Arnaud BondonCNRS, ISCR - UMR 6226, Univ Rennes, F-35000, Rennes, France.ORCID https://orcid.org/0000-0002-9229-6317
Soizic ChevanceCNRS, ISCR - UMR 6226, Univ Rennes, F-35000, Rennes, France.ORCID https://orcid.org/0000-0001-9699-5943
Marie-Laure Pinel-MarieINSERM, BRM - UMR_S 1230, Univ Rennes, F-35000, Rennes, France.ORCID https://orcid.org/0000-0001-5128-0741

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SprA1 and SprA2 are small hydrophobic peptides that belong to the type I toxin-antitoxin systems expressed by Staphylococcus aureus. Both peptides induce S. aureus death when overexpressed. Although they share 71% of amino acids sequence similarity, SprA2 exhibits stronger hemolytic activity than SprA1. In this study, we investigated the mode of action of these toxins on both prokaryotic-like and eukaryotic-like membranes. We first confirmed that SprA2, like SprA1, is an alpha-helical peptide located at the S. aureus membrane. By overexpressing each toxin, we demonstrated that SprA1 forms stable pores in the S. aureus membrane, evidenced by concomitant membrane depolarization, permeabilization and ATP release leading to growth arrest, whereas SprA2 forms transient pores, causing concomitant membrane depolarization, ATP release, and growth arrest. We showed that the unique cysteine residue present in SprA1 and SprA2 is required for toxicity through disulfide bond formation. Next, we found that both synthetic peptides induce slight leakage in anionic DOPC-DOPG lipid vesicles mimicking prokaryotic membranes, concomitant with lipid vesicles aggregation and/or fusion. Moreover, we observed that SprA1 permeabilizes S. aureus protoplasts, via its ability to form stable pores, whereas SprA2 permeabilizes and lyses them. However, no permeabilization of intact bacteria was detected after the addition of SprA1 and SprA2 in the extracellular medium. Finally, we confirmed that SprA2 has strong activity on zwitterionic DOPC lipid vesicles mimicking eukaryotic membranes, without inducing aggregation. This work highlights the strong selectivity of SprA2 for eukaryotic membranes, suggesting that this toxin may play a role in S. aureus virulence.

Indexed as

Bacterial ProteinsBacterial ToxinsCell MembranePeptidesStaphylococcus aureusToxin-Antitoxin SystemsAdenosine TriphosphateAmino Acid SequenceCell Membrane PermeabilityHemolysisAdenosine TriphosphateBacterial ProteinsBacterial ToxinsPeptidesmembrane‐active peptidemembrane depolarizationmembrane permeabilizationpore formationStaphylococcus aureustype I toxin–antitoxin system

Identifiers

PMID40033850
PMCPMC12414873

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.